查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1514977

疫苗合约製造市场，按疫苗类型、产品类型、应用、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Vaccine Contract Manufacturing Market, By Vaccine Type, By Product Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 265 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023 年疫苗合约製造市场规模为 29.0010 亿美元，2024 年至 2032 年复合年增长率为 8.00%。

疫苗合约製造市场-市场动态

疫苗和生物技术行业需求的成长预计将推动市场需求

由于疫苗接种计划的扩大、传染患者病率的增加以及对新疫苗来对抗新出现的病原体的需求，全球对疫苗的需求持续增长。这种需求促使製药公司寻求合约製造合作伙伴，以有效扩大生产规模。疫苗生产通常需要专门的设施、技术和专业知识。拥有成熟疫苗生产能力的合约製造商可以提供有效的解决方案，使製药公司能够专注于研究、开发和分销。因此，研究和技术的进步在市场成长中发挥着至关重要的作用。

疫苗生产受到 FDA 和 EMA 等世界各地卫生当局的严格监管。拥有成熟的监管合规专业知识的合约製造商可以加快审批流程并确保遵守品质标准，从而缩短新疫苗的上市时间。许多製药公司可能面临内部製造能力的限制。合约製造商提供额外的产能、灵活性和可扩展性，以满足全球疫苗需求和供应的波动。因此，为了提高製造能力，疫苗合约製造可以随着需求的变化而补充市场成长。

疫苗合约製造市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.00% 左右的复合年增长率成长

根据疫苗类型细分，由于病毒性疾病的高流行，减毒疫苗预计将在 2023 年显示最大的市场份额。

根据产品类型细分，由于单价疫苗类型较高，预计单一疫苗细分市场将在 2023 年显示最大市场份额。

根据应用细分，由于人类疫苗接种需求不断增长，人类使用细分是 2023 年的主要应用。

根据最终用户细分，由于製药公司在疫苗生产方面不断进行大量开发，製药公司细分市场将在 2023 年成为领先的最终用户。

从地区来看，由于顶级市场参与者的存在，北美是 2023 年的主要收入来源。

疫苗合约製造市场-細項分析：

全球疫苗合约製造市场根据疫苗类型、产品类型、应用、最终用户和地区进行细分。

根据疫苗类型，市场分为四类：减毒疫苗、灭活疫苗、基于 DNA 的疫苗和基于类毒素的疫苗。减毒疫苗市场占据主导地位。对病毒感染的高需求正在增加对减毒疫苗的需求。

市场依产品类型分为两类：单一疫苗和组合疫苗。单一疫苗领域主导市场。预计组合疫苗在预测期内将以最高速度成长。

依应用市场分为两类：人类使用和兽用。人类使用领域主导市场。人类对疫苗接种的需求不断增长，以避免病毒和严重疾病并对其进行预先免疫，这增加了细分市场的需求。

根据最终用户，市场分为三类：生物製药公司、研究实验室等。生物製药公司细分市场占据主导地位，预计在预测期内将保持其高度主导地位。生物製药公司对疫苗的需求和生产数量不断增加正在推动市场成长。

疫苗合约製造市场 - 地理洞察

在全球范围内，疫苗合约製造市场广泛分布于北美、拉丁美洲、欧洲、亚太地区、中东和非洲地区。在生产成本降低、生物製药行业不断发展以及医疗基础设施投资增加的推动下，亚太地区疫苗合约製造正在快速成长。印度和中国等国家正在成为全球疫苗供应链的关键参与者，在具有成本效益的製造和大规模生产能力方面提供竞争优势。

疫苗合约製造市场-竞争格局：

疫苗合约製造市场的特征是少数主要公司之间竞争激烈。主导市场的几家着名合约製造组织（CMO）包括龙沙（Lonza）、康泰伦特（Catalent）、三星生物製剂（Samsung Biologics）等。不断增长的需求。公司正在投资先进的生物技术平台和製造技术，以提高疫苗生产效率和产量。

最近的发展：

2023 年 10 月，Vaxcyte 和 Lonza Group 合作进行广谱肺炎链球菌结合疫苗 (PCV) 的全球商业生产。

2023 年 12 月，Ajinomoto Co., Inc. 购买了 All Forge Biologics Holdings, LLC 的股票。该设施的目标是提高生物製品的生产能力。

目录

第一章：疫苗合约製造市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按疫苗类型分類的疫苗合约製造市场片段
    • 按产品类型分類的疫苗合约製造市场片段
    • 按应用分類的疫苗合约製造市场片段
    • 最终用户的疫苗合约製造市场片段
    • 按国家/地区分類的疫苗合约製造市场片段
    • 按地区分類的疫苗合约製造市场片段
  • 竞争洞察

第 3 章：疫苗合约製造主要市场趋势

  • 疫苗合约製造市场驱动因素
    • 市场驱动因素的影响分析
  • 疫苗合约製造市场限制
    • 市场限制影响分析
  • 疫苗合约製造市场机会
  • 疫苗合约製造市场未来趋势

第 4 章：疫苗合约製造业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：疫苗合约製造市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：疫苗合约製造市场格局

  • 2023 年疫苗合约製造市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：疫苗合约製造市场 - 按疫苗类型

  • 概述
    • 按疫苗类型分類的细分市场份额分析
    • 减弱的
    • 灭活
    • 基于DNA
    • 基于类毒素

第 8 章：疫苗合约製造市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 单一疫苗
    • 联合疫苗

第 9 章：疫苗合约製造市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 人类使用
    • 兽医

第 10 章：疫苗合约製造市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 生物製药公司
    • 研究实验室
    • 其他的

第 11 章：疫苗合约製造市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美疫苗合约製造主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按疫苗类型）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲疫苗合约製造主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按疫苗类型）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区疫苗合约製造主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依疫苗类型）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲疫苗合约製造主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按疫苗类型）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲疫苗合约製造主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按疫苗类型）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 疫苗合约製造业

  • 竞争仪表板
  • 公司简介
    • Lonza Group
    • Emergent BioSolutions
    • Catalent
    • Vaxcyte
    • Samsung Biologics
    • Pfizer CentreOne
    • WuXi Biologics
    • Boehringer Ingelheim BioXcellence
    • Fujifilm Diosynth Biotechnologies
    • AGC Biologics
    • Rentschler Biopharma
    • Cytovance Biologics
    • Grand River Aseptic Manufacturing
    • KBI Biopharma
    • Vetter Pharma
    • Ajinomoto Co Inc.
    • CMC Biologics
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV3083

REPORT HIGHLIGHT

Vaccine Contract Manufacturing Market size was valued at USD 2,900.10 Million in 2023, expanding at a CAGR of 8.00% from 2024 to 2032.

The practice of a pharmaceutical firm (the contract manufacturer) producing vaccines for another corporation, or the client is known as vaccine contract manufacturing. Through this agreement, the customer can create vaccines under their specifications and needs by utilizing the contract manufacturer's manufacturing experience, facilities, and capabilities.

Vaccine Contract Manufacturing Market- Market Dynamics

Rising demand for vaccines and the biotechnology industry are expected to propel market demand

The global demand for vaccines continues to rise due to expanding vaccination programs, increasing the prevalence of infectious diseases, and the need for new vaccines to combat emerging pathogens. This demand drives pharmaceutical companies to seek contract manufacturing partners to scale up production efficiently. Vaccine manufacturing often requires specialized facilities, technologies, and expertise. Contract manufacturers with established capabilities in vaccine production can offer efficient solutions, enabling pharmaceutical companies to focus on research, development, and distribution. Thus, advancement in research and technology is playing a vital role in market growth.

Vaccine manufacturing is highly regulated by health authorities worldwide including FDA, and EMA. Contract manufacturers with established regulatory compliance expertise can expedite the approval process and ensure adherence to quality standards, reducing time to market for new vaccines. Many pharmaceutical companies may face limitations in their internal manufacturing capacities. Contract manufacturers provide additional capacity, flexibility, and scalability to meet fluctuating demand and supply vaccines globally. Therefore, to enhance manufacturing capabilities, vaccine contract manufacturing complements the market growth with changing demands.

Vaccine Contract Manufacturing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.00% over the forecast period (2024-2032)

Based on Vaccine Type segmentation, the attenuated segment was predicted to show maximum market share in the year 2023, owing to the high prevalence of viral illness.

Based on Product Type segmentation, the single vaccine segment was predicted to show maximum market share in the year 2023, owing to high monovalent vaccine types.

Based on Application segmentation, the human use segment was the leading Application in 2023, owing to the rising demand for vaccination among humans.

Based on End User segmentation, pharmaceutical companies' segment was the leading End User in 2023, owing to a high number of ongoing developments in pharma companies for vaccine manufacturing.

On the basis of region, North America was the leading revenue generator in 2023, owing to the presence of top market players.

Vaccine Contract Manufacturing Market- Segmentation Analysis:

The Global Vaccine Contract Manufacturing Market is segmented on the basis of Vaccine Type, Product Type, Application, End User, and Region.

The market is divided into four categories based on Vaccine Type: attenuated, inactivated, DNA-based, and toxoid-based. The attenuated vaccine segment dominates the market. High demand for viral infections is boosting the demand for attenuated vaccines.

The market is divided into two categories based on Product Type: single vaccine and combination vaccine. The single vaccine segment dominates the market. Combination vaccine is anticipated to grow at the highest rate during the forecast period.

The market is divided into two categories based on the Application: human use and veterinary. The human use segment dominates the market. The rising need for vaccination in human beings to avoid and pre-immune against viral & severe diseases is augmenting segment demand.

The market is divided into three categories based on End User: biopharmaceutical companies, research laboratories, and others. The biopharmaceutical companies segment dominates the market and is expected to maintain its high dominance during the forecast period. Increasing number of vaccines need & manufacturing at biopharma companies is fueling market growth.

Vaccine Contract Manufacturing Market- Geographical Insights

Worldwide, the Vaccine Contract Manufacturing market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The Asia-Pacific region is witnessing rapid growth in vaccine contract manufacturing, driven by lower production costs, growing biopharmaceutical industry, and increasing investments in healthcare infrastructure. Countries like India and China are becoming key players in global vaccine supply chains, offering competitive advantages in cost-effective manufacturing and large-scale production capabilities.

Vaccine Contract Manufacturing Market- Competitive Landscape:

The market for Vaccine Contract Manufacturing is characterized by stiff competition among few key companies. Several prominent contract manufacturing organizations (CMOs) dominate the market include Lonza, Catalent, Samsung Biologics, etc. These players in the vaccine contract manufacturing market are continuously expanding their production capacities to meet increasing demand. Companies are investing in advanced biotechnological platforms and manufacturing technologies to improve vaccine production efficiency and yield.

Recent Developments:

In October 2023, Vaxcyte and Lonza Group collaborated for global commercial manufacturing of broad-spectrum Pneumococcal Conjugate Vaccines (PCVs).

In December 2023, Ajinomoto Co., Inc. bought All Forge Biologics Holdings, LLC shares. The facility was targeted to boost production abilities for manufacturing biologics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET KEY PLAYERS

  • Lonza Group
  • Emergent BioSolutions
  • Catalent
  • Vaxcyte
  • Samsung Biologics
  • Pfizer CentreOne
  • WuXi Biologics
  • Boehringer Ingelheim BioXcellence
  • Fujifilm Diosynth Biotechnologies
  • AGC Biologics
  • Rentschler Biopharma
  • Cytovance Biologics
  • Grand River Aseptic Manufacturing
  • KBI Biopharma
  • Vetter Pharma
  • Ajinomoto Co Inc.
  • CMC Biologics
  • Others

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019-2032

  • Attenuated
  • Inactivated
  • DNA-based
  • Toxoid-based

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • Single vaccine
  • Combination vaccine

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Human Use
  • Veterinary

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Biopharmaceutical Companies
  • Research Laboratories
  • Others

GLOBAL VACCINE CONTRACT MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Vaccine Contract Manufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Vaccine Contract Manufacturing Market Snippet by Vaccine Type
    • 2.1.2. Vaccine Contract Manufacturing Market Snippet by Product Type
    • 2.1.3. Vaccine Contract Manufacturing Market Snippet by Application
    • 2.1.4. Vaccine Contract Manufacturing Market Snippet by End User
    • 2.1.5. Vaccine Contract Manufacturing Market Snippet by Country
    • 2.1.6. Vaccine Contract Manufacturing Market Snippet by Region
  • 2.2. Competitive Insights

3. Vaccine Contract Manufacturing Key Market Trends

  • 3.1. Vaccine Contract Manufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Vaccine Contract Manufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Vaccine Contract Manufacturing Market Opportunities
  • 3.4. Vaccine Contract Manufacturing Market Future Trends

4. Vaccine Contract Manufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Vaccine Contract Manufacturing Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Vaccine Contract Manufacturing Market Landscape

  • 6.1. Vaccine Contract Manufacturing Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Vaccine Contract Manufacturing Market - By Vaccine Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Vaccine Type, 2024 & 2032 (%)
    • 7.1.2. Attenuated
    • 7.1.3. Inactivated
    • 7.1.4. DNA-based
    • 7.1.5. Toxoid-based

8. Vaccine Contract Manufacturing Market - By Product Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 8.1.2. Single vaccine
    • 8.1.3. Combination vaccine

9. Vaccine Contract Manufacturing Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Human Use
    • 9.1.3. Veterinary

10. Vaccine Contract Manufacturing Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 10.1.2. Biopharmaceutical Companies
    • 10.1.3. Research Laboratories
    • 10.1.4. Others

11. Vaccine Contract Manufacturing Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Vaccine Contract Manufacturing Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Vaccine Contract Manufacturing Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Vaccine Contract Manufacturing Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Vaccine Contract Manufacturing Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Vaccine Contract Manufacturing Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Vaccine Contract Manufacturing Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Lonza Group
    • 12.2.2. Emergent BioSolutions
    • 12.2.3. Catalent
    • 12.2.4. Vaxcyte
    • 12.2.5. Samsung Biologics
    • 12.2.6. Pfizer CentreOne
    • 12.2.7. WuXi Biologics
    • 12.2.8. Boehringer Ingelheim BioXcellence
    • 12.2.9. Fujifilm Diosynth Biotechnologies
    • 12.2.10. AGC Biologics
    • 12.2.11. Rentschler Biopharma
    • 12.2.12. Cytovance Biologics
    • 12.2.13. Grand River Aseptic Manufacturing
    • 12.2.14. KBI Biopharma
    • 12.2.15. Vetter Pharma
    • 12.2.16. Ajinomoto Co Inc.
    • 12.2.17. CMC Biologics
    • 12.2.18. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Vaccine Contract Manufacturing Market: Vaccine Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Vaccine Type
  • TABLE Global Vaccine Contract Manufacturing Market, by Vaccine Type 2018-2030 (USD Million)
  • TABLE Vaccine Contract Manufacturing Market: Product Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Vaccine Contract Manufacturing Market, by Product Type 2018-2030 (USD Million)
  • TABLE Vaccine Contract Manufacturing Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Vaccine Contract Manufacturing Market, by Application 2018-2030 (USD Million)
  • TABLE Vaccine Contract Manufacturing Market: End User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Vaccine Contract Manufacturing Market, by End User 2018-2030 (USD Million)
  • TABLE Vaccine Contract Manufacturing Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Vaccine Contract Manufacturing Market, by Region 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by Vaccine Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Vaccine Contract Manufacturing Market, by End User, 2018-2030 (USD Million)

List of Figures

  • FIGURE Vaccine Contract Manufacturing Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Vaccine Type segment market share analysis, 2023 & 2030
  • FIGURE Vaccine Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Product Type segment market share analysis, 2023 & 2030
  • FIGURE Product Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End User segment market share analysis, 2023 & 2030
  • FIGURE End User segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE Europe Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE Asia Pacific Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE Latin America Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE Middle East and Africa Vaccine Contract Manufacturing Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Vaccine Contract Manufacturing Market share analysis by country, 2023
  • FIGURE Germany Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Vaccine Contract Manufacturing Market share analysis by country, 2023
  • FIGURE India Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Philippines Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Vaccine Contract Manufacturing Market share analysis by country, 2023
  • FIGURE Brazil Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Vaccine Contract Manufacturing Market share analysis by country, 2023
  • FIGURE Saudi Arabia Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Vaccine Contract Manufacturing Market size, forecast and trend analysis, 2018 to 2030 (USD Million)